BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 20673987)

  • 41. Primary immunodeficiencies: HSCT experiences of a single center in Turkey.
    Erol Cipe F; Adakli Aksoy B; Aydogdu S; Dikme G; Kiykim A; Aydogmus C; Yucel E; Bozkurt C; Fisgin T
    Pediatr Transplant; 2021 Nov; 25(7):e14063. PubMed ID: 34092004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hematopoietic stem cell transplantation for severe combined immunodeficiency.
    Hönig M; Schulz A; Friedrich W
    Klin Padiatr; 2011 Nov; 223(6):320-5. PubMed ID: 22052630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Severe combined immunodeficiency: The time for newborn screening has come].
    Hoyos Bachiloglu R; Sotomayor F C; Poli H C
    Rev Chil Pediatr; 2019 Dec; 90(6):581-588. PubMed ID: 32186580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
    de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
    Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe combined immunodeficiencies and related disorders.
    Fischer A; Notarangelo LD; Neven B; Cavazzana M; Puck JM
    Nat Rev Dis Primers; 2015 Oct; 1():15061. PubMed ID: 27189259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.
    Griffith LM; Cowan MJ; Kohn DB; Notarangelo LD; Puck JM; Schultz KR; Buckley RH; Eapen M; Kamani NR; O'Reilly RJ; Parkman R; Roifman CM; Sullivan KE; Filipovich AH; Fleisher TA; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1087-96. PubMed ID: 18992926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications.
    Mazzucchelli JT; Bonfim C; Castro GG; Condino-Neto AA; Costa NM; Cunha L; Dantas EO; Dantas VM; de Moraes-Pinto MI; Fernandes JF; Goes HC; Goudouris E; Grumach AS; Guirau LM; Kuntze G; Mallozzi MC; Monteiro FP; Moraes LS; Nudelman V; Pinto JA; Rizzo MC; Porto-Neto AC; Roxo-Junior P; Ruiz M; Rullo VE; Seber A; Takano OA; Tavares FS; Toledo E; Vilela MM; Costa-Carvalho BT
    J Investig Allergol Clin Immunol; 2014; 24(3):184-91. PubMed ID: 25011356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double cure: Omenn syndrome and β thalassaemia successfully treated with mismatched unrelated donor transplantation.
    Wootten V; Goulden N; Veys P; Qasim W
    Bone Marrow Transplant; 2012 Apr; 47(4):589-90. PubMed ID: 21602897
    [No Abstract]   [Full Text] [Related]  

  • 49. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening.
    Brown L; Xu-Bayford J; Allwood Z; Slatter M; Cant A; Davies EG; Veys P; Gennery AR; Gaspar HB
    Blood; 2011 Mar; 117(11):3243-6. PubMed ID: 21273302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency.
    Neven B; Leroy S; Decaluwe H; Le Deist F; Picard C; Moshous D; Mahlaoui N; Debré M; Casanova JL; Dal Cortivo L; Madec Y; Hacein-Bey-Abina S; de Saint Basile G; de Villartay JP; Blanche S; Cavazzana-Calvo M; Fischer A
    Blood; 2009 Apr; 113(17):4114-24. PubMed ID: 19168787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis.
    Speckmann C; Doerken S; Aiuti A; Albert MH; Al-Herz W; Allende LM; Scarselli A; Avcin T; Perez-Becker R; Cancrini C; Cant A; Di Cesare S; Finocchi A; Fischer A; Gaspar HB; Ghosh S; Gennery A; Gilmour K; González-Granado LI; Martinez-Gallo M; Hambleton S; Hauck F; Hoenig M; Moshous D; Neven B; Niehues T; Notarangelo L; Picard C; Rieber N; Schulz A; Schwarz K; Seidel MG; Soler-Palacin P; Stepensky P; Strahm B; Vraetz T; Warnatz K; Winterhalter C; Worth A; Fuchs S; Uhlmann A; Ehl S;
    J Allergy Clin Immunol; 2017 Apr; 139(4):1302-1310.e4. PubMed ID: 27658761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stem cell transplantation for primary immunodeficiencies: the European experience.
    Cavazzana M; Touzot F; Moshous D; Neven B; Blanche S; Fischer A
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):516-20. PubMed ID: 25304229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stem cell transplantation for treatment of primary immunodeficiency disorders.
    Müller SM; Friedrich W
    Iran J Allergy Asthma Immunol; 2005 Mar; 4(1):1-8. PubMed ID: 17301416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Umbilical cord stem cell transplantation for primary immunodeficiencies.
    Slatter MA; Gennery AR
    Expert Opin Biol Ther; 2006 Jun; 6(6):555-65. PubMed ID: 16706603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric hematopoietic SCT in Mexico: recent activity and main problems.
    Rodríguez-Romo L; González-Llano O; Mancias-Guerra C; Jaime-Pérez JC; Gómez-Peña A; Ruíz-Arguelles G; Ruíz-Delgado G; Olaya A; del Campo A; Montero I; González-Ramella O; Sandoval A; González G; Pompa T; Galindo C; Gómez-Almaguer D
    Bone Marrow Transplant; 2011 Apr; 46(4):607-9. PubMed ID: 20562923
    [No Abstract]   [Full Text] [Related]  

  • 56. Haematopoietic stem cell transplantation for severe combined immunodeficiency: Long-term health outcomes and patient perspectives.
    Lee AY; Frith K; Schneider L; Ziegler JB
    J Paediatr Child Health; 2017 Aug; 53(8):766-770. PubMed ID: 28513891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy.
    Jonkman-Berk BM; van den Berg JM; Ten Berge IJ; Bredius RG; Driessen GJ; Dalm VA; van Dissel JT; van Deuren M; Ellerbroek PM; van der Flier M; van Hagen PM; van Montfrans JM; Rutgers A; Schölvinck EH; de Vries E; van Beem RT; Kuijpers TW
    Clin Immunol; 2015 Feb; 156(2):154-62. PubMed ID: 25451158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT.
    Neven B; Ferrua F
    Front Pediatr; 2019; 7():552. PubMed ID: 32039114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful management of cutaneous BCG dissemination in a child affected by SCID and receiving allogeneic hematopoietic stem cell transplant.
    Naselli A; Losurdo G; Giardino S; Morreale G; Savioli C; Castagnola E
    Bone Marrow Transplant; 2015 Dec; 50(12):1572-3. PubMed ID: 26121110
    [No Abstract]   [Full Text] [Related]  

  • 60. Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency.
    Gennery AR; Lankester A;
    Front Pediatr; 2019; 7():381. PubMed ID: 31616648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.